Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The combination therapy was effective and well-tolerated, especially in young patients.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Enhancing immune response can improve cancer treatment effectiveness.

Brodalumab is more effective than ustekinumab in treating psoriasis.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.